Table of Contents
ISRN Ophthalmology
Volume 2011 (2011), Article ID 184295, 6 pages
http://dx.doi.org/10.5402/2011/184295
Research Article

Ginsenoside-Rb1 Induces ARPE-19 Proliferation and Reduces VEGF Release

Department of Biology, The University of Texas at San Antonio, San Antonio, TX 78249, USA

Received 18 October 2011; Accepted 10 November 2011

Academic Editors: A. Barak and H. Tomita

Copyright © 2011 Brandi S. Betts et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Nocerino, M. Amato, and A. A. Izzo, “The aphrodisiac and adaptogenic properties of ginseng,” Fitoterapia, vol. 71, no. 1, pp. S1–S5, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. S. L. Gray, B. R. Lackey, P. L. Tate, M. B. Riley, and N. D. Camper, “Mycotoxins in root extracts of American and Asian ginseng bind estrogen receptors α and β,” Experimental Biology and Medicine, vol. 229, no. 6, pp. 560–568, 2004. View at Google Scholar · View at Scopus
  3. K. W. Leung, L. W. T. Cheung, Y. L. Pon et al., “Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen β receptor,” British Journal of Pharmacology, vol. 152, no. 2, pp. 207–215, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. T. K. Yun, “Brief introduction of Panax ginseng C.A. Meyer,” Journal of Korean Medical Science, vol. 16, pp. S3–S5, 2001. View at Google Scholar · View at Scopus
  5. M. Yoon, H. Lee, S. Jeong et al., “Peroxisome proliferator-activated receptor is involved in the regulation of lipid metabolism by ginseng,” British Journal of Pharmacology, vol. 138, no. 7, pp. 1295–1302, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Einwallner, C. Ahlers, I. Golbaz et al., “Neovascular age-related macular degeneration under anti-angiogenic therapy: subretinal fluid is a relevant prognostic parameter,” Ophthalmologe, vol. 107, no. 2, pp. 158–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. R. Evans, “Risk Factors for age-related macular degeneration,” Progress in Retinal and Eye Research, vol. 20, no. 2, pp. 227–253, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Bossi and F. Koerner, “Retinopathy of prematurity,” Intensive Care Medicine, vol. 21, no. 3, pp. 241–246, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Miller, A. P. Adamis, and L. P. Aiello, “Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy,” Diabetes/Metabolism Reviews, vol. 13, no. 1, pp. 37–50, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. P. G. Steinkuller, L. Du, C. Gilbert, A. Foster, M. L. Collins, and D. K. Coats, “Childhood blindness,” Journal of the American Association for Pediatric Ophthalmology and Strabismus, vol. 3, no. 1, pp. 26–32, 1999. View at Google Scholar · View at Scopus
  11. F. Q. Liang and B. F. Godley, “Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration,” Experimental Eye Research, vol. 76, no. 4, pp. 397–403, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. W. R. Green, “Histopathology of age-related macular degeneration,” Molecular vision, vol. 5, p. 27, 1999. View at Google Scholar · View at Scopus
  13. C. W. Spraul, G. E. Lang, and H. E. Grossniklaus, “Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 37, no. 13, pp. 2724–2735, 1996. View at Google Scholar · View at Scopus
  14. R. Amin, J. E. Puklin, and R. N. Frank, “Growth factor localization in choroidal neovascular membranes of age- related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 35, no. 8, pp. 3178–3188, 1994. View at Google Scholar · View at Scopus
  15. D. W. Dawson, O. V. Volpert, P. Gillis et al., “Pigment epithelium-derived factor: a potent inhibitor of angiogenesis,” Science, vol. 285, no. 5425, pp. 245–248, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Ishibashi, Y. Hata, H. Yoshikawa, K. Nakagawa, K. Sueishi, and H. Inomata, “Expression of vascular endothelial growth factor in experimental choroidal neovascularization,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 235, no. 3, pp. 159–167, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Goodsell, “The molecular perspective: VEGF and angiogenesis,” Oncologist, vol. 7, no. 6, pp. 569–570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Matsumoto and L. Claesson-Welsh, “VEGF receptor signal transduction.,” Science's STKE, vol. 2001, no. 112, p. re21, 2001. View at Google Scholar · View at Scopus
  19. Z. Ablonczy, A. Prakasam, J. Fant, A. Fauq, C. Crosson, and K. Sambamurti, “Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through γ-secretase,” Journal of Biological Chemistry, vol. 284, no. 44, pp. 30177–30186, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Ferrara, K. Mayo, J. Cidlowski, N. Kochupillai, and G. Cutler, “Vascular endothelial growth factor and the regulation of angiogenesis,” Recent Progress in Hormone Research, vol. 55, pp. 15–36, 2000. View at Google Scholar · View at Scopus
  21. T. Qian and Z. Cai, “Biotransformation of ginsenosides Rb1, Rg3 and Rh2 in rat gastrointestinal tracts,” Chinese Medicine, vol. 5, article 19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. J. F. Cui, M. Garle, I. Björkhem, and P. Eneroth, “Determination of aglycones of ginsenosides in ginseng preparations sold in Sweden and in urine samples from Swedish athletes consuming ginseng,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 56, no. 2, pp. 151–160, 1996. View at Google Scholar · View at Scopus
  23. F. He, R. Guo, S. L. Wu, M. Sun, and M. Li, “Protective effects of ginsenoside Rb1 on human umbilical vein endothelial cells in vitro,” Journal of Cardiovascular Pharmacology, vol. 50, no. 3, pp. 314–320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Sengupta, S. A. Toh, L. A. Sellers et al., “Modulating angiogenesis: the yin and the yang in ginseng,” Circulation, vol. 110, no. 10, pp. 1219–1225, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Y. Ji, H. W. Lee, H. K. Kim et al., “Simultaneous determination of ginsenoside Rb1 and Rg 1 in human plasma by liquid chromatography-mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 35, no. 1, pp. 207–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. J. G. Grigsby, K. Parvathaneni, M. A. Almanza et al., “Effects of tamoxifen versus raloxifene on retinal capillary endothelial cell proliferation,” Journal of Ocular Pharmacology and Therapeutics, vol. 27, no. 3, pp. 225–233, 2011. View at Publisher · View at Google Scholar
  27. J. Harmey, Ed., VEGF and Cancer, Landes Bioscience, Georgetown, Tex, USA, 2004.
  28. J. Harmey, Ed., VEGF and Cancer, vol. 1, Landes Bioscience, Georgetown, Tex, USA, 2004.
  29. A. R. Rudnicka and J. Birch, Diabetic Eye Disease, Butterworth/Heinemann, Oxford, UK, 1st edition, 2000.